| Comprehensive lipid and lipid-related gene investigations of host immune responses to characterize metabolism-centric biomarkers for pulmonary tuberculosis NP Long, NK Anh, NTH Yen, NK Phat, S Park, VTA Thu, YS Cho, JG Shin, ... Scientific Reports 12 (1), 13395, 2022 | 12 | 2022 |
| A 10-gene biosignature of tuberculosis treatment monitoring and treatment outcome prediction NP Long, NK Phat, NTH Yen, S Park, Y Park, YS Cho, JG Shin Tuberculosis 131, 102138, 2021 | 10 | 2021 |
| Semi-automated therapeutic drug monitoring as a pillar toward personalized medicine for tuberculosis management RP Jayanti, NP Long, NK Phat, YS Cho, JG Shin Pharmaceutics 14 (5), 990, 2022 | 8 | 2022 |
| Multimodal plasma metabolomics and lipidomics in elucidating metabolic perturbations in tuberculosis patients with concurrent type 2 diabetes NTH Yen, NK Anh, RP Jayanti, NK Phat, DH Vu, JL Ghim, S Ahn, JG Shin, ... Biochimie 211, 153-163, 2023 | 6 | 2023 |
| Delineation of the molecular mechanisms underlying Colistin-mediated toxicity using metabolomic and transcriptomic analyses NP Long, JH Oh, SM Park, NTH Yen, NK Phat, YS Cho, HM Kim, S Yoon, ... Toxicology and Applied Pharmacology 439, 115928, 2022 | 6 | 2022 |
| Comprehensive lipid profiles investigation reveals host metabolic and immune alterations during anti-tuberculosis treatment: Implications for therapeutic monitoring NK Anh, NK Phat, NTH Yen, RP Jayanti, VTA Thu, YJ Park, YS Cho, ... Biomedicine & Pharmacotherapy 158, 114187, 2023 | 4 | 2023 |
| Pathway-level multi-omics analysis of the molecular mechanisms underlying the toxicity of long-term tacrolimus exposure NTH Yen, NK Phat, JH Oh, SM Park, KS Moon, VTA Thu, YS Cho, JG Shin, ... Toxicology and Applied Pharmacology 473, 116597, 2023 | 2 | 2023 |
| Genome-wide gene expression analysis reveals molecular insights into the drug-induced toxicity of nephrotoxic agents NTH Yen, SM Park, VTA Thu, NK Phat, YS Cho, S Yoon, JG Shin, DH Kim, ... Life Sciences 306, 120801, 2022 | 1 | 2022 |
| Metabolic phenotyping and global functional analysis facilitate metabolic signature discovery for tuberculosis treatment monitoring NK Anh, NTH Yen, NTN Tien, NK Phat, YJ Park, HS Kim, DH Vu, JY Oh, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 167064, 2024 | | 2024 |
| Alterations of lipid-related genes during anti-tuberculosis treatment: insights into host immune responses and potential transcriptional biomarkers NK Phat, NTN Tien, NK Anh, NTH Yen, YA Lee, HKT Trinh, KM Le, S Ahn, ... Frontiers in Immunology 14, 1210372, 2023 | | 2023 |
| Development of population pharmacokinetics model and Bayesian estimation of rifampicin exposure in Indonesian patients with tuberculosis S Soedarsono, RP Jayanti, NM Mertaniasih, T Kusmiati, A Permatasari, ... Tuberculosis 139, 102325, 2023 | | 2023 |
| Semi-Automated Therapeutic Drug Monitoring as a Pillar toward Personalized Medicine for Tuberculosis Management. Pharmaceutics 2022, 14, 990 RP Jayanti, NP Long, NK Phat, YS Cho, JG Shin s Note: MDPI stays neu-tral with regard to jurisdictional claims in …, 2022 | | 2022 |
| A Novel Transcriptomic Biosignature for Tuberculosis Diagnosis, Treatment Monitoring and Outcome Prediction NP Long, NTH Yen, Y Park, J Shin 대한결핵및호흡기학회 추계학술발표초록집 129, 598-598, 2021 | | 2021 |
| Evaluation of Clofazimine as a Potential Substrate and Inhibition on P-glycoprotein in Vitro R Jony, HJ Shin, Y Cho 대한결핵및호흡기학회 추계학술발표초록집 128, 614-614, 2020 | | 2020 |
Nguyen Phuoc LongInje University College of MedicineVerified email at inje.ac.kr
